Skip to content
Urofollitropin
Bravelle (urofollitropin) is an unknown pharmaceutical. Urofollitropin was first approved as Bravelle on 2002-05-06. It is used to treat female infertility and polycystic ovary syndrome in the USA. The pharmaceutical is active against follicle-stimulating hormone receptor.
Download report
Favorite
Commercial
Therapeutic Areas
Therapeutic Area
MeSH
neoplasmsD009369
urogenital diseasesD000091642
endocrine system diseasesD004700
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
Reference product - 351(a)
Reference product - 351(a)
Interchangeable product - 351(k)
Interchangeable product - 351(k)
Biosimilar product - 351(k)
Biosimilar product - 351(k)
Urofollitropin
Tradename
Proper name
Company
Number
Date
Products
BravelleurofollitropinFerring Pharmaceuticals Inc.N-21289 DISCN2002-05-06
1 products
Hide discontinued
Labels
FDA
EMA
No data
Indications
FDA
EMA
Indication
Ontology
MeSH
ICD-10
female infertilityEFO_0008560D007247N97
polycystic ovary syndromeEFO_0000660D011085E28.2
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
G: Genito urinary system and sex hormones
— G03: Sex hormones and modulators of the genital system
— G03G: Gonadotropins and other ovulation stimulants
— G03GA: Gonadotropins
— G03GA04: Urofollitropin
HCPCS
Code
Description
J3355
Injection, urofollitropin, 75 iu
Clinical
Clinical Trials
2 clinical trials
View more details
Mock data
Subscribe for the real data
Indications Phases 4
No data
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Retinitis pigmentosaD012174HP_0000580H35.52——1——1
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Macular degenerationD008268EFO_0001365H35.30—1———1
Indications Phases 1
No data
Indications Without Phase
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameUROFOLLITROPIN
INNurofollitropin
Description
Follitropin beta chain precursor (Follicle-stimulating hormone beta subunit) (FSH-beta)
Classification
Protein
Drug classtricyclic compounds; atropine derivatives
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)—
Identifiers
PDB—
CAS-ID146479-72-3
RxCUI134404
ChEMBL IDCHEMBL1201520
ChEBI ID—
PubChem CID—
DrugBankDB00094
UNII IDW9BB98U6HP (ChemIDplus, GSRS)
Target
Agency Approved
FSHR
FSHR
Organism
Homo sapiens
Gene name
FSHR
Gene synonyms
LGR1
NCBI Gene ID
2492
Protein name
follicle-stimulating hormone receptor
Protein synonyms
Follitropin receptor, FSH receptor
Uniprot ID
P23945
Mouse ortholog
Fshr (14309)
follicle-stimulating hormone receptor (Q9QWV8)
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Additional graphs summarizing 215 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
39 adverse events reported
View more details